[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
April 3, 2002

Federal Funding for Biomedical ResearchCommitment and Benefits

Author Affiliations

Author Affiliation: United States Senate Committee on Health, Education, Labor, and Pensions, Subcommittee on Public Health, Washington, DC.

JAMA. 2002;287(13):1722-1724. doi:10.1001/jama.287.13.1722

Fueled by rapidly increasing government funding, the pace of biomedical research has soared during the past decade. When I first entered medical school 3 decades ago, coronary artery bypass surgery was still in its infancy. Rapid improvements in pacemaker technology were being made, and noninvasive procedures to treat coronary disease were just beginning to be investigated. Today, applications of novel therapies and noninvasive procedures such as thrombolytic agents and percutaneous angioplasty are routine, pharmacologic agents such as calcium channel blockers and statins have been used for 20 years, and improved diagnostic tests such as single-photon emission computed tomography are widely used.

First Page Preview View Large
First page PDF preview
First page PDF preview
×